General Insights Hero 1920x480 (4:1)

Healthcare and Life Sciences Hot Topics: FDA Regulatory Considerations for Tobacco and Cannabis-Derived Substances

August 15, 2019
Washington, D.C. partners discuss new developments and considerations for tobacco and cannabis-derived substance regulation.
Washington, D.C. partners Ben Haas and Elizabeth Richards examine the “stand alone” area of tobacco and the new regulations around vaporized tobacco. In addition, they discuss FDA’s views on cannabis-derived substances and recent guidance for how these substances will be regulated moving forward.